Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gautier Marcq

Showing results (61-70 of 94) with videos related to

Pageof 10
Sort By:
Future Oncology (London, England)|April 27, 2026
Mitomycin for intravesical treatment of low-grade intermediate-risk non-muscle invasive bladder cancerLudovica Cella, Alessio Finocchiaro, Aleksander Ślusarczyk, et al.
Urologic Oncology|March 24, 2026
Endoscopic kidney-sparing surgery outcomes of high-grade upper tract urothelial cancerFrancesco Di Bello, Benjamin Pradere, Ekaterina Laukhtina, et al.
JMIR Research Protocols|June 15, 2023
Audit, Feedback, and Education to Improve Quality and Outcomes in Transurethral Resection and Single-Instillation Intravesical Chemotherapy for Nonmuscle Invasive Bladder Cancer Treatment: Protocol for a Multicenter International Observational Study With an Embedded Cluster Randomized TrialKevin Gallagher, Nikita Bhatt, Keiran Clement, et al.
European Urology Open Science|May 6, 2026
The Impact of II-look Ureteroscopy on Survival in Upper Tract Urothelial Carcinoma: A Multicenter Retrospective Study of EAU-YAU Urothelial Working GroupAndrea Gallioli, Francesco Di Bello, Ekaterina Laukhtina, et al.
BJU International|January 31, 2025
Global comparison of research ethical review protocols: insights from an international research collaborativeBing Jie Chow, Alexander Light, Arjun Nathan, et al.
BJU International|May 22, 2025
Contemporary outcomes in non-muscle-invasive bladder cancer: a large European multicentre studyMattia Longoni, Pietro Scilipoti, Mario De Angelis, et al.
BJU International|January 11, 2025
Gemcitabine and docetaxel for high-risk non-muscle-invasive bladder cancer: EuroGemDoce group resultsPietro Scilipoti, Mattia Longoni, Mario de Angelis, et al.
European Urology Oncology|February 20, 2026
Real-world Adherence to European Association of Urology-recommended Non-muscle-invasive Bladder Cancer Management: From Evidence-based Practice to Oncological OutcomesMattia Longoni, Pietro Scilipoti, Mario De Angelis, et al.
Targeted Oncology|November 13, 2024
Adjuvant Immune Checkpoint Inhibitors for Muscle-Invasive Urothelial Carcinoma: An Updated Systematic Review, Meta-analysis, and Network Meta-analysisTakafumi Yanagisawa, Keiichiro Mori, Akihiro Matsukawa, et al.
BJUI Compass|January 29, 2025
The significance of isolated de novo red patches in the bladder in patients referred with suspected urinary tract cancer: Results from the IDENTIFY studySinan Khadhouri, Kevin Gallagher, Kenneth R MacKenzie, et al.
Pageof 10

Showing results (61-70 of 94) with videos related to

Sort By:
Pageof 10
Future Oncology (London, England)|April 27, 2026
Mitomycin for intravesical treatment of low-grade intermediate-risk non-muscle invasive bladder cancerLudovica Cella, Alessio Finocchiaro, Aleksander Ślusarczyk, et al.
Urologic Oncology|March 24, 2026
Endoscopic kidney-sparing surgery outcomes of high-grade upper tract urothelial cancerFrancesco Di Bello, Benjamin Pradere, Ekaterina Laukhtina, et al.
JMIR Research Protocols|June 15, 2023
Audit, Feedback, and Education to Improve Quality and Outcomes in Transurethral Resection and Single-Instillation Intravesical Chemotherapy for Nonmuscle Invasive Bladder Cancer Treatment: Protocol for a Multicenter International Observational Study With an Embedded Cluster Randomized TrialKevin Gallagher, Nikita Bhatt, Keiran Clement, et al.
European Urology Open Science|May 6, 2026
The Impact of II-look Ureteroscopy on Survival in Upper Tract Urothelial Carcinoma: A Multicenter Retrospective Study of EAU-YAU Urothelial Working GroupAndrea Gallioli, Francesco Di Bello, Ekaterina Laukhtina, et al.
BJU International|January 31, 2025
Global comparison of research ethical review protocols: insights from an international research collaborativeBing Jie Chow, Alexander Light, Arjun Nathan, et al.
BJU International|May 22, 2025
Contemporary outcomes in non-muscle-invasive bladder cancer: a large European multicentre studyMattia Longoni, Pietro Scilipoti, Mario De Angelis, et al.
BJU International|January 11, 2025
Gemcitabine and docetaxel for high-risk non-muscle-invasive bladder cancer: EuroGemDoce group resultsPietro Scilipoti, Mattia Longoni, Mario de Angelis, et al.
European Urology Oncology|February 20, 2026
Real-world Adherence to European Association of Urology-recommended Non-muscle-invasive Bladder Cancer Management: From Evidence-based Practice to Oncological OutcomesMattia Longoni, Pietro Scilipoti, Mario De Angelis, et al.
Targeted Oncology|November 13, 2024
Adjuvant Immune Checkpoint Inhibitors for Muscle-Invasive Urothelial Carcinoma: An Updated Systematic Review, Meta-analysis, and Network Meta-analysisTakafumi Yanagisawa, Keiichiro Mori, Akihiro Matsukawa, et al.
BJUI Compass|January 29, 2025
The significance of isolated de novo red patches in the bladder in patients referred with suspected urinary tract cancer: Results from the IDENTIFY studySinan Khadhouri, Kevin Gallagher, Kenneth R MacKenzie, et al.
Pageof 10